Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New PR on share buyback

Meta, the buy back amount depends on how many settlements and for how much. Shareholders were told long ago 10% from each settlement would go toward buying back shares.  Turley can't give us an exact amount for future buybacks because he does not know who will settle, for how much, and when. He can only take it as it comes.

Go X2Y

Share
New Message
Please login to post a reply